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Formation of reactive aldehydes (MDA, HHE, HNE)
during the digestion of cod liver oil: comparison of
human and porcine in vitro digestion models
Cecilia Tullberg,*a Karin Larsson,a Nils-Gunnar Carlsson,a Irene Comi,b
Nathalie Scheers,a Gerd Vegarudb and Ingrid Undelanda
In this work, we investigated lipid oxidation of cod liver oil during gastrointestinal (GI) digestion using two
types of in vitro digestion models. In the ﬁrst type of model, we used human GI juices, while we used
digestive enzymes and bile from porcine origin in the second type of model. Human and porcine models
were matched with respect to factors important for lipolysis, using a standardized digestion protocol. The
digests were analysed for reactive oxidation products: malondialdehyde (MDA), 4-hydroxy-trans-2-
nonenal (HNE), and 4-hydroxy-trans-2-hexenal (HHE) by liquid chromatography/atmospheric pressure
chemical ionization-mass spectrometry (LC/APCI-MS), and for free fatty acids (FFA) obtained during the
digestion by gas chromatography-mass spectrometry (GC-MS). The formation of the oxidation products
MDA, HHE, and HNE was low during the gastric digestion, however, it increased during the duodenal
digestion. The formation of the oxidation products reached higher levels when digestive juices of human
origin were used (60 µM of MDA, 0.96 µM of HHE, and 1.6 µM of HNE) compared to when using enzymes
and bile of porcine origin (9.8, and 0.36 µM of MDA; 0.16, and 0.026 µM of HHE; 0.23, and 0.005 µM of
HNE, respectively, in porcine models I and II). In all models, FFA release was only detected during the
intestinal step, and reached up to 31% of total fatty acids (FA). The ﬁndings in this work may be of impor-
tance when designing oxidation oriented lipid digestion studies.
Introduction
Marine long-chain n-3 polyunsaturated fatty acids (LC n-3
PUFA), commonly known as marine omega-3, have attracted
interest due to their positive health eﬀects.1 Intake of LC n-3
PUFA in the form of fish oil or as eicosapentaenoic acid (EPA)/
docosahexaenoic acid (DHA) supplements has been associated
with reduced risk of many diseases, e.g. cardiovascular2–4 and
inflammatory diseases.5–7 LC n-3 PUFA have also been linked
with a protective eﬀect on cancer.8–10 However, meta-analyses
of studies done on e.g. cardiovascular disease have shown
ambiguous results, suggesting that there might be factors
aﬀecting the reported beneficial eﬀects of LC n-3 PUFA.11–15
Concerns regarding the involvement of LC n-3 PUFA oxidation
have been raised lately,16,17 and there is a need to examine the
interference of oxidized LC n-3 PUFA on the cardio-protective,
anti-inflammatory, and anticancer eﬀects of these fatty acids
(FA).18,19 Fish oil generally contains both LC n-3 and LC n-6
PUFA, with LC n-3 PUFA being paramount. However, the levels
of LC n-3 and n-6 PUFA are highly varying in marine foods, e.g.
depending on the fish species, feed,20 and seasonal vari-
ations.21 Marine LC n-6 PUFA are likewise known to be suscep-
tible to oxidation, hence are also of interest when studying
lipid oxidation of fish oil.
The possibility that the gastrointestinal (GI) tract is an
environment enhancing lipid oxidation was suggested in the
beginning of the 21st century.22,23 We and other authors have
since then revealed that fish lipids can be oxidized under GI
conditions in in vitro studies, when using digestive enzymes of
porcine and fungal origin.24,25 Oxidative and pro-inflammatory
responses have also been shown when corresponding digests
were added to yeast, Saccharomyces cerevisiae ZIM 2155, and
human dendritic cells.26 That lipid oxidation can take place
during the digestion of dietary lipids has also been supported
in vivo in a study using mini-pigs.27 Lipid oxidation has
additionally been found to occur when human gastric juice
(HGJ) was used in in vitro model digestion of herring oil.28
However, to our knowledge, no two-step in vitro digestion,
including both a gastric and a duodenal step, with human GI
juices has been used to study oxidation of marine lipids
previously.
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The lipid oxidation reaction is known to generate highly
reactive oxidation products that may negatively interact e.g.
with DNA and proteins, leading to the dysfunction of cells.
Some of these reactive oxidation products are the α,β-unsatu-
rated aldehydes malondialdehyde (MDA), 4-hydroxy-trans-2-
hexenal (HHE), and 4-hydroxy-trans-2-nonenal (HNE),29 see
Fig. 1. The extensively studied molecule MDA has previously
been in focus as an unspecific biomarker of lipid oxidation
and as a molecule with possible negative eﬀects on health.30
MDA has been suggested to possess carcinogenic and geno-
toxic properties, and has additionally been linked with toxicity
towards the cardiovascular system.30 It has been shown that
MDA can be derived from several diﬀerent precursor mole-
cules, but the main origin is PUFA, and MDA is strongly linked
to lipid oxidation in biological matrixes.30 HNE and to some
extent HHE, have also caught attention as toxic marker mole-
cules for lipid oxidation, HHE as an aldehyde derived from n-3
PUFA,31,32 and HNE from n-6 PUFA.31,33 Both HHE and HNE
have been shown to be cytotoxic, genotoxic, and carcinogenic
in biological systems, and react in a similar way since they are
both hydroxyalkenals.29 However, there are some diﬀerences in
the specific targets when HHE and HNE react with proteins,
and there are additional diﬀerences in the metabolic pathways
of HHE and HNE.34 This emphasises the detection of both the
hydroxyalkenals as biomarkers for lipid oxidation. Since both
n-3 PUFA and n-6 PUFA are found in fish oils, the formation of
HHE and HNE is of importance when studying lipid oxidation
in marine matrixes. However, little is known about the extent
of MDA, HHE, and HNE formation in the human GI tract
during the digestion of marine foods and supplements. In a
recent study, the eﬀect of a diet with oxidized lipids was
assessed in mice, and it was found that the plasma levels
of HHE accumulated over time.35 In the same study, the
absorption of HHE and the formation of protein adducts in
the small intestine of mice were observed, following the
administration of HHE, indicating that HHE can be absorbed,
but also that it may cause local damage in the GI tract.35
Kenmogne-Domguia et al.36 recently investigated lipid oxi-
dation of stabilized marine oil emulsions, containing a
mixture of tuna oil, oleic sunflower oil, and sunflower oil,
during in vitro digestion using porcine enzymes. They found
that both oxygen uptake and MDA formation increased over
digestion time and that the highest levels were found in the
intestinal phase.36 Detecting levels of the three reactive
aldehydes MDA, HHE, and HNE simultaneously in digests of
fish oil would give insights into the potential toxicity caused
by the oxidation in the GI tract. MDA in marine oil has com-
monly been monitored together with other carbonyls as part
of the thiobarbituric acid reactive substance (TBARS) test,24,36
or with high-performance liquid chromatography (HPLC).37
Analysis of accumulated HHE and HNE in fish or vegetable oil
has commonly been done by GC-MS.36,38 According to the lit-
erature,39 liquid chromatography/atmospheric pressure chemi-
cal ionization-mass spectrometry (LC/APCI-MS) should allow
their separation and detection in one run.
In vitro digestion models of today are usually based on
enzymes and bile of porcine origin, either as extracts of bile
and/or pancreatin, or as pure enzymes.40 The use of human GI
juices for in vitro digestion studies is however uncommon. It
has previously been shown that peptides derived from the
digestion of whey proteins with human GI juices diﬀer from
those formed during digestion with enzymes and bile of
porcine origin.41 The diﬀerences observed might be due to the
specificities of the GI enzymes or other conditions used. It has
not been thoroughly studied how human and porcine-based in
vitro digestion models diﬀer when it comes to levels and types
of pro- or anti-oxidants, which could highly influence the
outcome of the oxidation-oriented lipid digestion studies. In
response to a high variability of porcine-based in vitro diges-
tion models, a standardized static in vitro digestion model was
developed through the COST Action project InfoGest.40 This
was done in order to harmonize diﬀerent protocols, and thus
researchers are able to compare diﬀerent digestion studies.
This study was conducted during the development of the
InfoGest protocol and is therefore highly influenced by it.
The aim of this study was to compare the formation of reac-
tive lipid oxidation products of cod liver oil during digestion
using an in vitro model based on human digestive juices, and
digestive models comprising enzymes and bile of porcine
origin. The lipolytic release of free fatty acids (FFA) was
additionally compared between the models. To confirm that
the digestion models were properly matched, the enzyme
activities were monitored. The formation of the reactive lipid
oxidation-derived aldehydes MDA, HHE, and HNE was ana-
lysed using a combined applied LC/APCI-MS method.
Materials and methods
Chemicals
Pepsin from porcine gastric mucosa (655 U mg−1, Fluka-
77163), pancreatin from porcine pancreas (4 × USP, Sigma-
P1750), and porcine bile extract (Sigma-B8631) were obtained
from Sigma Aldrich (Saint Louis, USA). HHE and HNE were
purchased from Cayman (Ann Arbor, USA). A Milli-Q plus
system (Merck Millipore, Darmstadt, Germany) was used to
purify water to a minimum resistance of 18.2 MΩ cm. All other
chemicals, such as solvents used, were at least of analytical
grade.
Fig. 1 Chemical structure of malondialdehyde (MDA), 4-hydroxy-trans-
2-hexenal (HHE), and 4-hydroxy-trans-2-nonenal (HNE).
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Samples
The sample used in the digestion studies was refined cod liver
oil. The oil did not contain any added antioxidants and was
supplied by Lýsi hf (Reykjavík, Iceland). Expressed as peak area
(%) of the detected total FA methyl esters (FAME), the oil con-
tained 24.4% n-3 PUFA (8.2% EPA and 10.5% DHA), and 1.3%
n-6 PUFA.42 In total it contained 27.5% PUFA, 48% MUFA, and
17.2% SFA42 (Table 1). Human gastric juice (HGJ) and human
duodenal juice (HDJ) were aspirated from four and five volun-
teers, respectively, as described by Ulleberg et al.43 and Holm
et al.44 The volunteers were healthy and semi-fasting. In short,
a triple lumen tube (Maxter Catheters, Marseille, France) was
used for the aspiration of digestive juices, and was placed in
the correct position of the volunteer by gastroscopy. A stimu-
latory solution was introduced by the tube (100 mL h−1), while
the aspirates were collected close to the papilla of Vater in the
duodenum, and from the canalis ventriculi in the stomach. The
pH, volume, and enzyme activities of the aspirates from the
stomach and the duodenum were assayed. Individual aspirates
were pooled to eliminate individual eﬀects as much as poss-
ible, and the samples were stored at −80 °C. The aspirations
were carried out at Lovisenberg Diakonale Hospital, Oslo,
Norway, from June to September 2013. The study was per-
formed with approval from the Norwegian Regional Ethics
Committee (project no. 2012/2230, Biobank no. 2012/2210).
The Declaration of Helsinki was followed, and all participants
in the study signed up as volunteers with informed consent.
Characterization of human juices
Factors important for lipolysis were analysed and compared
when using the two digestion models. The chosen factors
were: pancreatic lipase activity, bile-salt concentration, and
calcium ion concentration. Pancreatic lipase contributes to a
major part of the lipolysis in the body,45 while bile-salt is
needed for micelles to form in the small intestine. Bile-salt
additionally aﬀects lipolysis by inhibiting pancreatic lipase in
the absence of co-lipase.45 Ionic calcium enhances the activity
of e.g. pancreatic phosphatide 2-acylhydrolase,45 and at high
concentrations also causes soap formation, precipitating the
FFA, calcium, and bile salt together.46
The total protein concentration was initially measured to
standardize the porcine model I and human model against
each other, since the total protein levels detected in the HGJ
and HDJ were related to the concentrations of enzymes added
in the porcine model I (see the section “In vitro static digestion
models”). Haemoglobin and trace metal ions were analysed in
the human juices, since they are potent pro-oxidants.47,48
Measurements to characterize the human juices were carried
out in triplicate, unless otherwise stated.
Pancreatic lipase activity. Pancreatic lipase activity was
assayed in HDJ at the time of collection (day 2) and after
11 months of storage at −80 °C. This was done according to
Ulleberg et al.43 by using a colorimetric assay kit, LIP (Roche
Diagnostics GmbH, Mannheim, Germany), using 1,2-O-
dilauryl-rac-glycero-3-glutaric acid-(6-methylresorufin) as the
substrate, which is a non-diglyceride chromogenic substrate.
Lipase activity was additionally measured using a titrimetric
protocol described by Minekus et al.40 Pancreatic lipase activity
in HDJ was calculated in U mL−1 using tributyrin as the
substrate.
Total protein concentration. Total protein concentrations in
HGJ and HDJ were analysed using a Qubit Fluorometer in com-
bination with a Quant-ITTM protein assay kit (Invitrogen Co.,
Carlsbad, CA, USA), according to the instructions provided by
the manufacturer.
Bile-salt concentrations. The bile-salt concentration in HDJ
was measured using the ADVIA 1650 clinical system (Bayer
Healthcare, Tarrytown, NY, USA) for automated analysis. A bile
acid kit (Bio-stat Diagnostic systems, Stockport, UK) was used
to spectrophotometrically (410 nm) determine the bile-salt
concentration. The analysis was based on the formation of
Thio-NADH, due to the action of the enzyme 3α-hydroxysteroid
dehydrogenase, and standardized against taurocholic acid.
Measurements were carried out in duplicate at the Central
Laboratory of the Norwegian School of Veterinary Science
(Oslo, Norway).
Calcium ion concentration. Calcium ion concentrations in
HGJ and HDJ were measured using a Dionex HPLC BioLC
system (Thermo Scientific, Sunnyvale, USA) with a CG14 guard
column, combined with an IonPac CS14 analytical column (4 ×
250 mm). The BioLC was combined with a CD20 conductivity
detector, a GS50 gradient pump, and a Spark Holland auto-
sampler (Triathlon, Sunnyvale, the Netherlands). A CMMS3
Table 1 Fatty acid composition of cod liver oil from Lýsi hf. Results are
expressed in peak area (%) of total fatty acid methyl esters (FAME), n =
2. EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, doco-
sahexaenoic acid; SFA, saturated fatty acids; MUFA, monounsaturated
fatty acids; PUFA, polyunsaturated fatty acids. Table reprinted from
Jónsdóttir et al.42 with permission from John Wiley and Sons
FAME
Area
(%)
Conc. of lipids
(mg g−1)
C14:0 3.9 41
C16:0 10.4 112
C16:1n-7 6.3 67
C16:2n-4 0.7 7
C18:0 2.2 24
C18:1n-11 2.2 24
C18:1n-9 13.9 149
C18:1n-7 4.1 44
C18:2n-6 1.3 14
C18:3n-3 0.7 8
C20:1n-11 1.9 21
C20:1n-9 9.4 102
C20:1n-7 0.5 6
C18:4n-3 2.0 21
C22:1n-9 8.3 91
C20:3n-3 1.1 12
C20:4n-3 0.7 8
C20:5n-3 (EPA) 8.2 89
C22:5n-3 (DPA) 1.2 13
C22:6n-3 (DHA) 10.5 114
Sum SFA 17.2 —
Sum MUFA 48.0 —
Sum PUFA 27.5 —
Food & Function Paper
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4 mm suppressor was placed before the detector. Analysis was
done using 9 mM methanesulphonic acid as a mobile phase.
Samples were measured under isocratic conditions, with the
flow rate 0.9 mL min−1, and 20 µL per sample was injected at
room temperature. Standards of Ca2+, as CaCl2, in the range
0.01–10 ppm, were used, and analysis showed linearity within
this chosen region. Data collection and analysis were carried
out with the help of Dionex Chromeleon software (Thermo
Scientific, Sunnyvale, USA).
Analysis of trace metal ions and haemoglobin. Analysis of
trace metal ions in HDJ, as well as in porcine bile and pancrea-
tin of porcine origin was carried out according to the method
by Fredrikson et al.49 External standards for Cu, Ni, Zn, Co,
Mn, and Fe were used. Acidic microwave digestion of the
samples was followed by separation and detection on ion
chromatography coupled with UV-vis spectroscopy. Total haem
pigment content was analysed according to the method by
Hornsey,50 using bovine haemoglobin as an external standard.
Detection was done spectrophotometrically at 640 nm.
Analysis of porcine pancreatic and bile extracts
The porcine pancreatic extract was analysed for lipase activity,
using the method described by Minekus et al.40 and recorded
in U mg−1. Bile-salt concentrations (mM), ionic calcium con-
centrations (mM), and total protein concentrations (mg mL−1)
in the porcine-bile extracts and pancreatin were analysed in
the same way as the human juices. Bile-salt concentrations
were measured three times (each time n = 2) in the bile
extracts, due to large variations in the results. A mean value of
the bile-salt concentration was used in the design of the
in vitro digestion model.
In vitro static digestion models
In this study, a static in vitro digestion model with human GI
juices and another with porcine enzymes and bile was used.
For the first part of the study, the work in progress protocol by
Minekus et al.40 was used, and this porcine model is referred
to as “porcine model I”. The amounts of enzymes used in the
porcine model I were based on the total protein levels detected
in the HGJ and HDJ, according to Aarak et al.51 This is the
reason why the human model and the porcine model I diﬀer
in regard to the dilution of the initial meal, and the recorded
enzyme activities, see Table 2. Based on one of the highlighted
points of the published InfoGest standardized protocol,40
enzyme activities important for lipid digestion were measured
again, and from the results, a second porcine model, referred
to as “porcine model II”, was achieved according to the final
protocol of Minekus et al.40 adjusting the porcine lipase activi-
ties, bile-salt, and calcium ion levels to the same levels as
those found in human GI juices. The protocol for gastric and
duodenal digestion was followed, omitting the oral salivary
α-amylase due to the lack of carbohydrates in the food matter.
In all the digestion models, sampling of the digests was
carried out after 10, 30, 60, and 120 min in the gastric step,
and after 10, 30, 60, and 90 min in the duodenal step. Tubes
with digests were stored at −80 °C directly after sampling. A
comprehensive overview of the porcine models I and II, and
the human digestion model is shown in Table 2. Table 3
shows an overview of the simulated GI solutions used, based
Table 2 Digestion parameters in the gastric and intestinal step of the porcine models (I and II) and human model. n.a.: samples not analyzed
Digestion parameters
Porcine model I
stomach
Porcine model I
duodenum
Porcine model II
stomach
Porcine model II
duodenum
Human
stomach
Human
duodenum
Dilution of the initial meal (oil + water) 1 : 2 1 : 6 1 : 2 1 : 15 1 : 2 1 : 15
pH 3 7 3 7 3 7
Lipase activitya (U mL−1) n.a. 23d n.a. n.a., 570d n.a. 570 and 190c
Lipase activityb (U mL−1) n.a. 17 n.a. 510 n.a. 140c
Bile-salt conc. (mM) n.a. 4.7 n.a. 2.6 n.a. 2.6
Ca2+ conc. (mM) 1.46 0.63 0.32 0.34 0.32 0.34
Total protein conc. (mg mL−1) n.a., 0.3e n.a., 0.68e n.a. n.a. 0.3 0.69
a The lipase activity measured by the colorimetric method described by Ulleberg et al.43 b The lipase activity measured by the titrimetric method
described by Minekus et al.40 cMeasured after 11 months of storage at −80 °C. dCalculated with a conversion factor between the (a) and (b)
lipase activity methods. eCalculated according to mg enzyme per mL added to the digestion model, assuming that all proteins detected were
enzymes.
Table 3 Simulated GI solutions used in the porcine models I and II. pH was adjusted by adding sodium hydroxide (NaOH) (1 M), sodium bicarbonate
(NaHCO3) (0.15 M), and hydrochloric acid (HCl) (1 M). Calcium (CaCl2(H2O)2) was added later into the digestion model
Simulated GI
solution
KCl
(mM)
KH2PO4
(mM)
NaHCO3
(mM)
NaCl
(mM)
MgCl2(H2O)6
(mM)
(NH4)2CO3
(mM) pH
CaCl2(H2O)2
(mM)
Gastric, porcine I 35 0.9 13 41.1 0.6 — 3 0.4
Duodenal, porcine I 6.8 0.8 85 32.9 0.33 — 7 0.4
Gastric, porcine II 6.9 0.9 25 47.2 0.1 0.5 3 0.4
Duodenal, porcine II 6.8 0.8 85 38.4 0.33 — 7 0.4
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on the work in progress protocol (porcine model I), and the
final protocol (porcine model II) of Minekus et al.40 Control
samples of only human juices or porcine enzymes diluted in
the simulated gastric/duodenal solutions were included in the
digestion models and collected at 120 and 210 min for the
gastric and the duodenal step, respectively.
In vitro digestion, porcine models I and II. The digestion
model set up included oil mixed with water (0.13 mg mL−1) as
the initial meal. The samples were flushed with N2 gas for
20 s. The ratio between the initial food and the digestive steps
followed the standardized protocol by Minekus et al.40 For the
gastric phase pepsin (0.45 mg mL−1 in the final gastric step)
was added to simulate the gastric fluid, and in addition
CaCl2(H2O)2 (1.5 µL, 0.4 M) simulated the gastric solution
(Table 3), and water was added to the initial meal. The pH was
adjusted to pH 3 by adding HCl (1 M). During the gastric step,
the tubes were kept in the dark (37 °C, 50 rpm). After the
gastric step (120 min), CaCl2(H2O)2 (3 µL, 0.4 M), simulated
duodenal solution (Table 3) with porcine bile (20 mg mL−1)
and pancreatin (2.4 mg mL−1), and water was added to the
samples. The pH was corrected to pH 7 by adding NaOH (1 M)
and NaHCO3 (0.15 M). During the duodenal step, the tubes
were kept in the dark (37 °C, 250 rpm). Porcine model II was
modified to match the human model based on lipase activity,
bile-salt, and ionic calcium concentration, as well as the
dilution of the initial meal, see Table 2. Other than this, the
porcine model II followed the same procedure as model I.
In vitro digestion, human digestion model. The human
digestion model followed the same procedures as the porcine
models, with respect to oxygen reduction, incubation intervals,
mixing rate, sampling etc. HGJ (0.8 mL) was added to cod liver
oil and water, the pH was adjusted to 3 by the addition of
NaHCO3 (0.15 M), and the samples were kept in the dark
(37 °C, 50 rpm). HDJ (6.4 mL) was added and the pH adjusted
to 7 by adding NaOH (1 M) before further incubation (37 °C,
250 rpm), and sampling at regular intervals for 90 min.
Lipid extraction and analysis of free fatty acids (FFA)
Lipid extraction. Lipids were extracted from the undigested
(control) and digested samples (gastric and duodenal) accord-
ing to Bligh and Dyer,52 with modifications according to Lee
et al.53 Throughout the procedure, the samples were covered
with aluminium foil and kept on ice in order to prevent oxi-
dation. The fatty acid heptadecanoic acid (C17:0), was added
from the start to all samples as an internal standard. Due to
large sample volumes, separation funnels (size 50–200 mL)
were used for the extraction of samples from the gastric and
duodenal steps of the human model and porcine model II. All
other samples were extracted in glass tubes (15 mL). CHCl3–
MeOH in ratios 2 : 1 and 1 : 2, was used in the high-fat (fat
content >6%) and low-fat (fat content <2%) samples, respect-
ively, and 0.05% (w/v) butylated hydroxytoluene (BHT) was
added to the samples (10 : 1). After mixing, NaCl (0.5%) was
added (1 : 2.75). The tubes were then vortexed (10 s) and the
separation funnels were turned 3 × 2 times and shaken (10 s).
The tubes were then centrifuged (3000g, 6 min) and the separ-
ation funnels were kept in a cold room (4 °C) until phase sep-
aration had occurred. The chloroform phase was withdrawn
and evaporated to dryness (N2 gas, 40 °C).
Analysis of FFA. Lipids were dissolved in a small volume of
chloroform before loading on Telos NH2 SPE-columns (500 mg
per 6 mL) (Kinesis, St Neots, UK). Lipid classes (neutral lipids,
phospholipids and FFA) were separated according to Kaluzny
et al.54 Heneicosanoic acid (C21:0) was used as an additional
standard to study losses during the solid phase extraction
(SPE). The FFA fraction was collected, the solvent (CHCl3) was
evaporated to dryness (N2 gas, 40 °C) and FFA were methylated
by the in-house methanolic-HCl transesterification method
described by Cavonius et al.55 The following modifications
were applied: toluene (2 mL) was added to the lipid residues,
followed by the addition of 10% (v/v) MeOH : acetylchloride
(2 mL); the samples were methylated at 60 °C, for 150 min,
whereafter the reaction was terminated by water (1 mL).
Petroleum ether (2 mL) was then added to extract the FFA. The
samples were vortexed and centrifuged (2500g, 5 min) and
the organic phase was analysed using GC-MS according to
Cavonius et al.55 with the external fatty acid standard mix
GLC 463 (Nu-Chek Prep, Inc., Elysian, USA).
Analysis of total fatty acids (FA). Total FA were methylated
and analysed in the same way as the FFA, but without separ-
ation on SPE-columns into lipid classes. FA methyl esters were
then detected as FAME.
Determination of HHE, HNE, and MDA
Non-protein bound lipid oxidation products HHE, HNE, and
MDA were analysed by 2,4-dinitrophenylhydrazine (DNPH)
(Brady’s reagent) derivatization of aldehydes and LC/APCI-MS
analyses by a method developed from the analytical principles
described by Grosjean et al.,39 Deighton et al.,56 Andreoli
et al.57 and Sakai et al.58 Undigested samples (control),
digested samples (gastric and duodenal) and standards were
mixed with BHT (1 : 25 BHT to sample, 4.5 M in MeOH) and
ethylenediaminetetraacetic acid (EDTA) disodium salt (1 : 13
EDTA to sample, 0.02 M). Acidification was carried out with
HCl (1 : 1.12, 0.25 M) and the samples were vortexed and left
for precipitation for 5 min.
After precipitation, the samples were centrifuged (16 000g,
2 min) and DNPH (25 µL, 10 mM in MeOH) was added to the
supernatant (0.4 mL), before vortexing and incubation (25 °C,
60 min). Two extractions were then carried out with dichloro-
methane (0.5 mL), during which the samples were vortexed
(10 s) and centrifuged (16 000g, 2 min) before the lower phase
was transferred into new tubes. The samples were evaporated
to dryness (N2 gas, 25 °C) and the residues diluted in MeOH
(0.25 mL), vortexed and centrifuged (16 000g, 2 min), and the
supernatants were transferred into vials.
Stocks of HNE (1 mg in 100 µL EtOH), and HHE (1 mg in
100 µL MeOH) were used as external standards for HNE and
HHE, and 1,1,3,3-tetraethoxypropane (TEP) (1 mM), hydrolysed
in H2SO4 (1%) (25 °C, 120 min), was used as an external
standard for MDA. Concentrations of the stock solutions
were determined spectrophotometrically (λMDA = 245 nm,
Food & Function Paper
This journal is © The Royal Society of Chemistry 2016 Food Funct., 2016, 7, 1401–1412 | 1405
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
0 
Ja
nu
ar
y 
20
16
. D
ow
nl
oa
de
d 
on
 0
9/
08
/2
01
6 
08
:1
9:
48
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
εMDA in acidic H2O = 13 700; λHHE = 219 nm, εHHE in MeOH =
13 750; λHNE = 221 nm, εHNE in EtOH = 16 000). External stan-
dard mixtures with diﬀerent concentrations of MDA, HHE,
and HNE were included in each sequence in the LC/APCI-MS.
The analysis was performed on an Agilent 1260 HPLC
system, consisting of a binary pump, an auto sampler, a
column oven, and an UV-detector, coupled to an Agilent 6120
quadrupole in the APCI negative mode (Agilent Technologies,
Waldbron, Germany). The separation was performed on a
Phenomenex Luna, 4.6 mm i.d. × 250 mm, 3 µm, C18 columns
(Phenomenex, Macclesfield, UK), at a flow rate of 0.7 mL
min−1 and injection volume of 15 µL, using a gradient at
50 °C. Analysis of the data was carried out using the Agilent
ChemStation (Agilent Technologies, Böblingen, Germany) soft-
ware program. N2 gas was used for nebulisation (40 psig),
drying was carried out at 350 °C, and vaporization was carried
out at 450 °C, all other MS conditions were set according to
Grosjean et al.39
The mobile phases were: A: MeOH, with 20 mM HAc, and
B: water, with 20 mM HAc. A gradient program was followed
for 40 min, which started with A (70%) and B (30%) in 2 min,
then A increased linearly to 95% over 8 min. 95% of eluent A
and 5% of B were then maintained for 10 min. Another linear
increase started at 20 min and continued for 5 min to reach
98% of eluent A and 2% of eluent B. This setting was main-
tained for 2 min, then eluent A was reduced linearly to 70%
over 1 min. 70% of eluent A and 30% of eluent B were main-
tained until the end of the gradient program.
Data acquisition was carried out in selected ion monitoring
(SIM) modes, and the ions were collected at 234.0, 293.1, and
335.1 m/z at fragmentor settings 50, 150, and 170, respectively.
UV detection was performed at 264 nm, to confirm the
analysis.
Validation of the method showed that the inter-day vari-
ation was 0.99% (standard deviations) of MDA, 2.1% of HHE,
1.2% of HNE. Linearity was controlled for: MDA, R2 = 0.985
(0.025–100 µM), HHE, R2 = 0.997 (0.01–10 µM), and HNE, R2 =
0.997 (0.005–10 µM). Limit of quantification is defined as a
signal-to-noise ratio above 10. Between day variation and
repeatability in digested samples was within 10% for all
aldehydes.
Statistics
Statistical analysis of the data was performed using IBM SPSS
statistics version 22 (IBM Corporation, New York, USA). Diﬀer-
ences between the human and the porcine models were deter-
mined by using two-tailed Student’s t-test. Unequal variance
was assumed and the significance level was p = 0.05.
Results and discussion
The scope of this study was to analyse and compare lipid oxi-
dation of cod liver oil during digestion in two types of static
in vitro digestion models. The porcine models I and II were based
on porcine bile and GI commercial enzymes; commonly used
when studying digestion, and the human model was based on
human GI juices. The lipid oxidation products analysed were
the aldehydes MDA, HHE, and HNE. The results from the
development of the in vitro GI digestion models and from ana-
lyses of lipolysis and oxidation during digestion are presented
below.
In vitro digestion based on human GI juices and GI
commercial enzymes
To adjust the porcine model II to the human model, important
factors for lipolysis were analysed and compared. An overview
of these diﬀerent factors is shown in Table 2. The bile-salt con-
centration in the pooled human duodenal juice (2.6 mM) was
low compared to what is recommended in the standard proto-
col.40 This is probably due to the 12 hours fasting of the volun-
teers prior aspiration. In a review by McConnell et al.59 the
bile-salt output in the food stimulated state is reported to be
11 mM. The bile secretion is activated by the ingestion of food,
and in a fasting state the production is fairly low (0.6–5 mM).59
Previous reports of bile-salt concentration of HDJ has been
shown to be in the range between 3–5 mM in pooled aspirated
samples.43,60,61 The lipase activity of the pooled HDJ was lower
than recommended in the standardized protocol, 570 U mL−1
versus 2000 U mL−1.40 However, it was decided to use the
natural content of bile and lipase as it occurred in the human
juices, and not add the commercial porcine bile or lipase.
The ionic calcium concentration in HDJ correlated quite
well with the values used in the standardized protocol,
0.34 mM versus 0.3 mM.40 In the pooled HGJ, higher levels
were recorded than those recommended in the standardized
protocol.40 To make the human and porcine models compar-
able, a higher ionic calcium concentration than recommended
was therefore added in the gastric step of the porcine model II.
Lipolysis during in vitro digestion of cod liver oil
No FFA increase was observed during the gastric digestion in
any of the static in vitro digestion models, however, during
intestinal digestion lipolysis occurred in both the porcine and
the human models (Fig. 2). This is in line with earlier analyses,
showing that no active gastric lipase was found in either HGJ
or in the porcine pepsin (data not shown). As presented in
Fig. 2, the lipolysis in the duodenal step reached similar levels
in the human model and porcine model II showing that the
lipolysis by the pancreatic lipase was comparable in these
models. The level of lipolysis after 210 min in the human
digestion model and the porcine model II was 31% and 26%,
respectively, with no significant diﬀerence between the
models. When comparing the human digestion model (31%)
with porcine model I (16%), a significant diﬀerence (p < 0.005)
was seen after the duodenal digestion (t = 210 min). This is
most probably due to diﬀerences in lipase activity that was 25-
fold lower in the porcine model I compared to the porcine
model II and the human model. The levels of released FFA
during digestion are in accordance with lipolysis levels
reported in in vitro digestion of marine lipids. If expressed as
% FFA release of total oil (mg), we see a 21%, 11% and 18%
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release in the porcine model I, porcine model II, and human
model, respectively (t = 210 min). Zhu et al.62 showed approxi-
mately 15% release of FFA after the digestion of fish oil, Aarak
et al.63 showed a 20% release of FFA after the digestion of
salmon muscle, and Larsson et al.24 showed a 40% release of
FFA of total oil (mg) after the digestion of cod liver oil; all
three using static pancreatic lipase based in vitro models;
Larsson et al.24 with gastric lipase from Rhizopus oryzae added
in the gastric step. Several factors determine the final lipolysis
level, such as pH,64 presence of calcium,46,64 bile-salt levels,46
lipase activity,65 and droplet size of the emulsified oil.66 It is
therefore no surprise that the porcine model I diﬀered from
the human digestion model and the porcine model II,
although the basic settings were comparable.
When analysing the content of free EPA and DHA during
and after the digestion, see Table 4, no major diﬀerence was
seen between the three models in the gastric step (t =
120 min), except that the levels of free EPA and DHA in the
porcine model I decreased twofold, compared to the other
models. The detected levels of free EPA and DHA decreased in
all models compared to what was found in the initial oil. This
could be due to consumption of these FFA in the lipid oxi-
dation reaction. Previous studies have shown that FFA are
more susceptible to lipid oxidation than the intact triglycer-
ides.67,68 Also, FFA can attract pro-oxidative metals and thus
co-oxidize triglycerides.69 In the duodenal step (t = 210 min),
the lipolysis results diﬀered between models in that a higher
release of EPA was observed in the human model compared to
the porcine models I and II (960% increase during digestion,
compared to 450% and 570%, respectively). The same obser-
vation was made for DHA, with a higher release in the human
model compared to the porcine models I and II (230%
increase during digestion, compared to 490% and 680%,
respectively). This supports the findings of Aarak et al.51 that
there are diﬀerences in the release of EPA and DHA when
using human versus porcine digestive enzymes. According to
above, there could be a link between the release of free EPA/
DHA and the extent of lipid oxidation in the duodenal step.
Larsson et al.24 found a link between total lipolysis and TBARS
development in the gastric and duodenal step of a porcine
static model. The importance of specific FFA released during
digestion and its relation to lipid oxidation needs to be investi-
gated further.
The lipid oxidation products MDA, HHE, and HNE
The lipid oxidation products MDA, HHE, and HNE were
observed during gastric digestion in the human model, but
none of the three products were identified in the gastric part
of the porcine models (Fig. 3). During duodenal digestion,
aldehydes were identified in both the human model and the
porcine models I and II. A significantly (p < 0.05) higher
accumulation of aldehydes occurred in the human model com-
pared to the two porcine models, with the exception at t =
150 min for HHE and HNE, where the diﬀerences were insig-
nificant (p > 0.05). The aldehyde levels in all models decreased
in the order: MDA > HHE > HNE. This is in accordance with
the levels detected in human plasma samples, as reviewed by
Pillon and Soulage,70 with MDA being found at the highest
concentration, followed by HHE and HNE. Control samples
without oil were run in parallel with the oil samples, see
Table 5. These were analysed at the end of the gastric and
intestinal step, in order to check how much the digestive com-
ponents contributed to the lipid oxidation levels. The control
samples showed that some lipid oxidation products were
present in the digestive fluids alone, relative to each specific
aldehyde and time point. The relatively high control values
recorded at 120 min in human juices could indicate that the
lipid oxidation reaction had already started in the human GI
juices, which could explain the pronounced increase of
recorded lipid oxidation products in the human model. In the
porcine model II the HNE levels were larger in the control
samples, than in oil-fortified samples, which could be due to
the low levels of HNE detected (HNE < 0.01 µM). The lowest
standard included to detect HNE was however even lower
Fig. 2 Release of free fatty acids (FFA) during gastric (120 min) and
duodenal (90 min) digestion of cod liver oil. Results are shown as %
of FFA per detected total fatty acids (FA) in cod liver oil. Error bars
show SD, n ≥ 3.
Table 4 Detection of free fatty acids (FFA) % during digestion, compared to initial levels detected in the cod liver oil. EPA, eicosapentaenoic acid;
DHA, docosahexaenoic acid
Gastric step (120 min) Duodenal step (210 min)
FFA Porcine model I Porcine model II Human model Porcine model I Porcine model II Human model
EPA (%) −60 −30 −40 450 570 960
DHA (%) −60 −30 −30 490 680 1230
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Fig. 3 Lipid oxidation products in the digests during gastric (0–120 min) and duodenal (120–210 min) digestion of cod liver oil. Malondialdehyde
(MDA), 4-hydroxy-trans-2-hexenal (HHE), and 4-hydroxy-trans-2-nonenal (HNE). Gastric step is shown in panels (A) MDA, (C) HHE, and (E) HNE, and
duodenal step is shown in panels (B) MDA, (D) HHE, and (F) HNE. Note the diﬀerent scales on the y-axis in the panels. Error bars show SD, n ≥ 3,
except for samples from the porcine model I at time 130 min, where n = 2. Signiﬁcant diﬀerences were seen between the human digestion model
and both porcine models I and II, in the ﬁgures shown as *p < 0.05, **p < 0.005, and ***p < 0.001. In a few time points, a signiﬁcant diﬀerence
(p < 0.05) was seen between porcine models I and II as well; MDA (t = 120 min, 130 min, and 180 min), HHE (t = 180 min), and HNE (t = 150 min).
Table 5 Levels of aldehydes reached in control samples (without oil) at the end of the gastric (t = 120 min) and intestinal (t = 210 min) step. Data
for the control samples are expressed as % of the samples with oil. MDA, malondialdehyde; HHE, 4-hydroxy-trans-2-hexenal; HNE, 4-hydroxy-
trans-2-nonenal
Aldehyde
Porcine model I
(120 min)
Porcine model I
(210 min)
Porcine model II
(120 min)
Porcine model II
(210 min)
Human model
(120 min)
Human model
(210 min)
MDA (%) 2.4 74 47 4.0 40 0.18
HHE (%) 1.5 28 5.6 0.0 30 0.29
HNE (%) 1.7 57 180 180 37 9.7
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(0.005 µM), and is still within the limits of quantification of
the method.
We expected to see some lipid oxidation in the gastric step,
however, this was not the case in any of the models. Our
hypothesis was that the gastric environment, with low pH,
oxygen, and pro-oxidants present in the bolus, would induce
lipid oxidation, according to the suggestions by Kanner and
Lapidot22 and Halliwell et al.23 Also, Kristinova et al.28
observed that lipid oxidation, measured by TBARS, PV, and
oxygen uptake rate, was induced by the low pH itself, rather
than the enzymes in the gastric juice. Lipid oxidation during
in vitro digestion of cod liver oil, minced mullet muscle, and
herring oil has also been previously observed in the gastric
step.24,25,28 In these studies, less specific methods like TBARS,
peroxide value (PV), and conjugated dienes were however used,
and relatively low levels were detected. One possible expla-
nation for the lack of lipid oxidation in the gastric step in our
study could be the lack of gastric lipolysis, see Fig. 2. Lipase
has sometimes been added in the gastric step in other in vitro
digestion studies, e.g. in the study by Larsson et al.24 We did
not add any gastric lipase in the porcine models, as gastric
lipase is not a part of the standard protocol described by
Minekus et al.40 Even though the presence, levels and role of
gastric lipase are still debated, since it has been discovered
relatively recently, it is believed to contribute to 10–25% of the
lipolysis during digestion.45 When Larsson et al.24 omitted the
gastric enzymes and only incubated cod liver oil at 37 °C with
the pH-cycle of the GI tract, no significant increase in the
levels of TBARS was observed. This supports the theory that
lipid oxidation in the gastric step is correlated to the presence
of active gastric lipase. It is possible that the gastric lipase
activity in the HGJ was lost during our collection/storage of the
aspirates, since it is easily digested by pepsin at low pH.
Another possible explanation is that there were antioxidants
present in the HGJ, which prevented the lipid oxidation reac-
tion from being initiated. It is also possible that other para-
meters of the digestion models are important for the
formation of lipid oxidation products, such as GI tract contrac-
tion/movements, or gastric digestion time.
To make the data comparable with what was reported by
Larsson et al.26 and Kenmogne-Domguia et al.36 concen-
trations were recalculated from µM in the digests to µM in the
lipid phase, see Table 6. Using LC with a diode array detector
(DAD), Larsson et al.26 found an average level of total MDA
that was 4 and 10 times higher compared to what was found in
porcine models I and II in this study. This could be due to
diﬀerences in the analysis method and in the in vitro digestion
protocol, since the oil used was identical to the oil in our
study. However, there were also diﬀerences in the used simu-
lated electrolyte solutions, enzyme concentrations and bile-salt
concentrations, and also in the detection methods, which
could explain the diﬀerent MDA levels found. Kenmogne-
Domguia et al.36 studied lipid oxidation using stabilized
marine oil emulsions; protein-stabilised emulsion (PSE) and
phospholipid-stabilised emulsion (PpSE), and reported that
the levels of MDA are in line with the levels found in this
study, see Table 6. Larsson et al.26 measured HHE concen-
tration by LC/APCI-MS during the digestion of cod liver oil
with porcine enzymes and bile, and found levels similar to
what was detected in all digestion models in our study. Ken-
mogne-Domguia et al.36 reported HHE concentrations in the
digests, using PSE and PpSE, and the levels are 11–40 times
higher compared to what was found in the porcine models of
this study, but approximately 3.5 times lower than what was
found in the human model, see Table 6. The diﬀerences could
be due to the addition of the pro-oxidant metmyoglobin in
their in vitro digestion model, the use of a pre-emulsified oil
mixture, or a higher oil : enzyme ratio.36 The HNE levels found
in our models also diﬀer with the HNE levels recorded in the
two diﬀerently stabilized oil emulsions (PSE and PpSE) by Ken-
mogne-Domguia et al.36 being 50 times higher in their study
compared to what was detected in this study. Apart from the
mentioned metmyoglobin addition, this discrepancy is likely
to be caused by the oil emulsions used by Kenmogne-Domguia
et al.36 containing 10% n-6 FA, compared to 1% n-6 FA in the
cod liver oil used in this study. The maximum levels of alde-
hydes at 210 min observed in this study were 43, 203, and
5657 µmol per kg lipid (MDA), 7.7, 27.2, and 951 µmol per kg
lipid (HHE), and 1.4, 0.82, and 44 µmol per kg lipid (HNE) in
the porcine model I, porcine model II, and human model,
respectively. The low levels of HNE compared to MDA and
HHE are in accordance with the low levels of LC n-6 PUFA in
cod liver oil, 1.3 area% of detected total FA.42 On comparing
this with the total amount of n-3 and n-6 PUFA in the oil, we
obtained 1.9, 6.6, and 230 µmol HHE per kg n-3 FA, and 0.02,
0.01, and 0.6 µmol HNE per kg n-6 FA, in the porcine model I,
porcine model II and human model, respectively. This indi-
cates that the n-3 PUFA in the cod liver oil was generally more
susceptible towards oxidation compared to the n-6 PUFA. This
could be due to a higher unsaturation degree in the n-3 PUFA
Table 6 Comparison between lipid oxidation levels reported in two diﬀerent studies and this study, in the duodenal step, t = 180 min. Values
recalculated to be presented as µmol kg−1. PSE, protein-stabilised emulsion; PpSE, phospholipid-stabilised emulsion; MDA, malondialdehyde;
HHE, 4-hydroxy-trans-2-hexenal; HNE, 4-hydroxy-trans-2-nonenal. n.a.: samples not analyzed
Aldehyde
Larsson
et al.26
Kenmogne-Domguia et al.36
(PSE)
Kenmogne-Domguia et al.36
(PpSE)
Porcine
model I
Porcine
model II
Human
model
MDA (µmol kg−1) 445 3300 7200 42 140 4465
HHE (µmol kg−1) 5.1 231 216 6.2 20 797
HNE (µmol kg−1) n.a. 51 59 1.3 0.70 45
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fraction compared to n-6 PUFA fraction in the cod liver oil, see
Table 1. A comparison of the HHE and HNE levels to the total
amount of free n-3 and n-6 PUFA detected after digestion (t =
210 min) supports this theory, and in the porcine model I,
porcine model II, and human model we can report the for-
mation of 0.75, 2.1, and 48 µmol HHE per mg n-3 FA, and
0.14, 0.074, and 5.7 µmol HNE per mg n-6 FA, respectively.
This also indicates that there might be a correlation between
the level of free n-3 and n-6 PUFA present and the suscepti-
bility towards lipid oxidation.
We did not expect pronounced diﬀerences between the
porcine and the human models with respect to MDA, HHE,
and HNE after the duodenal step. Aarak et al.51 observed that
the total amount of FFA released from salmon oil was similar
to that when using a porcine and a human duodenal model,
even if higher relative levels of EPA and DHA were released
when using HDJ for digestion compared to porcine pancreatic
enzymes. The same was observed in this study, and since FFA
as well as more highly unsaturated PUFAs are known to be
more susceptible to oxidation than esterified/more saturated
FA, this could be an explanation for the diﬀerence in oxidation
between the human and the porcine digestion models. To our
knowledge, no previous study has looked at dissimilarities
between a human and a porcine model from a lipid oxidation
perspective, and there might be several factors influencing the
higher occurrence of lipid oxidation during digestion with
human GI juices, e.g. the presence of pro-oxidants, like iron.
Preliminary analysis of minerals showed that trace metal ions,
such as iron, were hardly detectable (<0.5 ppm, data not
shown). However, when analysing total haem pigment content,
approximately 3 times higher haem pigment content in HDJ
than in the other samples was seen (data not shown). This
could be due to minor internal bleedings during aspiration,
possibly caused by the insertion of the three-lumen tube for
the collection of the HDJ. The result from the analysis of total
haem pigment content could also however be due to colour
interference by bilirubin or other bile complexes formed. This
could explain the lack of correlation between iron and haem
analyses. Further investigation of the cause of the diﬀerent
lipid oxidation levels in the two digestion models needs to
be done.
Knowledge regarding the importance of lipid oxidation
product formation during digestion is still limited. The bio-
logical role of α,β-unsaturated aldehydes, such as MDA, HHE,
and HNE, is extensively discussed, and the toxicity and reacti-
vity of the products are being evaluated. MDA, HHE, and HNE
can form Michael and Schiﬀ base adducts with proteins,
which could lead to various biological eﬀects depending on
the original role of the altered proteins. The reactivity of the
α,β-unsaturated aldehydes can also be directed towards phos-
pholipids, causing major damage to biological membranes,
where HNE appears to be more reactive than HHE.71 The reac-
tivity towards cysteine-, lysine-, and histidine groups, by
Michael addition followed by an attack on a nucleophilic
group (e.g. in DNA), makes α,β-unsaturated aldehydes quite
genotoxic.29,72 HHE and HNE are known to be cytotoxic to
cells, and in the review by Pillon and Soulage,70 LC50 levels of
20–60 µM after a long incubation time were reported for
various animal and human cells; while LC50 for MDA was
reported to be ≥600 µM.70 These levels are higher than the
levels reported in this study at 180 min digestion; the closest
are the levels of HHE found in the human digestion model
(9.8 µM). Still, in vitro cellular damage has been reported at
lower levels, a 70% inhibition of the cell growth and induced
apoptosis was for example observed by Cerbone et al.73 using
human Caco-2 cells and HNE (1 µM). Bae et al.74 reported the
induction of HHE dose-dependent apoptosis in human epi-
thelial renal proximal tubular cells, starting already at 10 µM
HHE. If the lipid oxidation products are absorbed, they could
potentially cause systemic eﬀects. In a review by Chapple
et al.75 diﬀerent dose-dependent eﬀects of HNE on in vitro cel-
lular signalling were reported. Antioxidant defence and inflam-
matory response are enhanced at low HNE levels, however at
higher doses, cell viability decreases and apoptosis is
induced.75 The possible eﬀects of lipid oxidation products on
epithelial cells in the GI tract may diﬀer and are still rather
undiscovered. The ability of lipid oxidation products to be
absorbed have been proven in vivo in rats,35 and also recently
in our dynamic in vitro digestion study.76 However, to what
extent this could happen in the human body, and what impli-
cations it would have on human health remains unclear.
Conclusion
In conclusion, reactive aldehydes (MDA, HHE, and HNE) were
formed from cod liver oil during intestinal digestion using
both human and porcine in vitro models. However, when com-
paring the human and porcine models with respect to oxi-
dation, significantly higher generation of MDA, HHE, and
HNE was observed during digestion with human GI enzymes
and bile. The reason for the diﬀerence is still unknown;
however, it may be due to qualitative diﬀerences in the release
of FFA during digestion, or the presence of pro-oxidants like
haem in the human GI juice. This finding may be important
to bear in mind when using in vitro digestion models for study-
ing lipid oxidation.
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EDTA Ethylenediaminetetraacetic acid
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FAME Fatty acid methyl esters
FA Fatty acids
FFA Free fatty acids
GC-MS Gas chromatography-mass spectrometry
GI Gastrointestinal
HDJ Human duodenal juice
HGJ Human gastric juice
HHE 4-Hydroxy-trans-2-hexenal
HNE 4-Hydroxy-trans-2-nonenal
HPLC High-performance liquid chromatography
LC/APCI-MS Liquid chromatography/atmospheric pressure
chemical ionization-mass spectrometry
LC n-3 PUFA Long-chain n-3 polyunsaturated fatty acids
LC n-6 PUFA Long-chain n-6 polyunsaturated fatty acids
MDA Malondialdehyde
PSE Protein-stabilised emulsion
PpSE Phospholipid-stabilised emulsion
PV Peroxide value
SPE Solid phase extraction
TBARS Thiobarbituric acid reactive substances
TEP 1,1,3,3-Tetraethoxypropane
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